ISPD CARDIOVASCULAR AND METABOLIC GUIDELINES IN ADULT PERITONEAL DIALYSIS PATIENTS PART II - MANAGEMENT OF VARIOUS CARDIOVASCULAR COMPLICATIONS

被引:45
|
作者
Wang, Angela Yee Moon [1 ]
Brimble, K. Scott [2 ]
Brunier, Gillian [3 ]
Holt, Stephen G. [4 ]
Jha, Vivekanand [5 ]
Johnson, David W. [6 ,7 ]
Kang, Shin-Wook [8 ]
Kooman, Jeroen P. [9 ]
Lambie, Mark [10 ]
McIntyre, Chris [11 ]
Mehrotra, Rajnish [12 ]
Pecoits-Filho, Roberto [13 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada
[3] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[4] Univ Melbourne, Royal Melbourne Hosp, Div Nephrol, Melbourne, Vic 3050, Australia
[5] George Inst Global Hlth India, Postgrad Inst Med Educ & Res, Chandigarh, India
[6] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia
[7] Translat Res Inst, Ctr Kidney Dis Res, Brisbane, Qld, Australia
[8] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Dept Internal Med, Seoul 120749, South Korea
[9] Univ Hosp Maastricht, Div Nephrol, Maastricht, Netherlands
[10] Keele Univ, Inst Sci & Technol Med, Hlth Serv Res Unit, Keele ST5 5BG, Staffs, England
[11] Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Derby, England
[12] Univ Washington, Harborview Med Ctr, Dept Med, Div Nephrol, Washington, DC USA
[13] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2015年 / 35卷 / 04期
关键词
Coronary artery disease; heart failure; left ventricular hypertrophy; stroke; peripheral artery disease; atrial fibrillation; sudden cardiac death; peritoneal dialysis; STAGE RENAL-DISEASE; NONVALVULAR ATRIAL-FIBRILLATION; LEFT-VENTRICULAR HYPERTROPHY; PERIPHERAL ARTERIAL-DISEASE; HEALTH-CARE PROFESSIONALS; SUDDEN CARDIAC DEATH; HEMODIALYSIS-PATIENTS; HEART-FAILURE; DILATED CARDIOMYOPATHY; PROGNOSTIC VALUE;
D O I
10.3747/pdi.2014.00278
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular mortality has remained high in patients on peritoneal dialysis (PD) due to the high prevalence of various cardiovascular complications including coronary artery disease, left ventricular hypertrophy and dysfunction, heart failure, arrhythmia (especially atrial fibrillation), cerebrovascular disease, and peripheral arterial disease. In addition, nearly a quarter of PD patients develop sudden cardiac death as the terminal life event. Thus, it is essential to identify effective treatment that may lower cardiovascular mortality and improve survival of PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendation statements regarding lifestyle modification, assessment and management of various cardiovascular risk factors, and management of the various cardiovascular complications to be published in 2 guideline documents. This publication forms the second part of the guideline documents and includes recommendation statements on the management of various cardiovascular complications in adult chronic PD patients. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. We also define areas where evidence is clearly deficient and make suggestions for future research in each specific area.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 50 条
  • [41] Cardiovascular morbidity and mortality risk factors in peritoneal dialysis patients
    Jovanovic, Dijana B.
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 (5-6) : 313 - 318
  • [42] Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis
    Garcia-Lopez, Elvia
    Carrero, Juan J.
    Suliman, Mohamed E.
    Lindholm, Bengt
    Stenvinkel, Peter
    PERITONEAL DIALYSIS INTERNATIONAL, 2007, 27 : S205 - S209
  • [43] The Effect of Using Statin for Cardiovascular Prevention in Peritoneal Dialysis Patients
    Wu, Ping-Hsun
    Lin, Yi-Ting
    Kuo, Mei-Chuan
    Chiu, Yi-Wen
    Chen, Hung-Chun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 377 - 377
  • [44] PERITONITIS AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS IN PERITONEAL DIALYSIS PATIENTS
    Hepburn, K.
    Lambert, K.
    Mullan, J.
    Mcalister, B.
    Lonergan, M.
    Hassan, H.
    NEPHROLOGY, 2018, 23 : 95 - 95
  • [45] Vascular calcification inhibitors and cardiovascular events in peritoneal dialysis patients
    Olmaz, Refik
    Selen, Tamer
    Gungor, Ozkan
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (02) : 169 - 181
  • [46] Effect of hemoglobin volatility on cardiovascular prognosis in peritoneal dialysis patients
    杨文娟
    ChinaMedicalAbstracts(InternalMedicine), 2021, 38 (03) : 179 - 179
  • [47] Alteration of Cardiovascular Structure and Function in Patients Undergoing Peritoneal Dialysis
    Rebic, Damir R.
    Rasic, Senija R.
    Dervisevic, Muamer D.
    Hamzic-Mehmedbasic, Aida H. M.
    Muslimovic, Alma M.
    Hasanagic, Edina H.
    CardioRenal Medicine, 2015, 5 (02) : 135 - 144
  • [48] INSULIN RESISTANCE AS A PREDICTOR OF CARDIOVASCULAR DISEASE IN PATIENTS ON PERITONEAL DIALYSIS
    Li, Yun
    Zhang, Lihua
    Gu, Yong
    Hao, Chuanming
    Zhu, Tongying
    PERITONEAL DIALYSIS INTERNATIONAL, 2013, 33 (04): : 411 - 418
  • [49] Nontraditional risk factors for cardiovascular disease in patients on peritoneal dialysis
    Nitta, Kosaku
    RENAL REPLACEMENT THERAPY, 2024, 10 (01)
  • [50] A RISK MODEL TO PREDICT CARDIOVASCULAR MORTALITY IN PERITONEAL DIALYSIS PATIENTS
    Xia, X.
    Luo, Q.
    Lin, Z.
    Lin, J.
    Yang, X.
    Huang, F.
    Yu, X.
    NEPHROLOGY, 2016, 21 : 97 - 97